G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: Impact of a public health advisory and subsequent reports in the news media
TL;DR: Medical information regarding fetal and infant safety, disseminated in the public domain, should be transferred in a way that does not influence a pregnant woman to make decisions that may not be in the best interest of hers or her child's health.
Journal ArticleDOI
Safety of lidocaine-prilocaine cream in the treatment of preterm neonates☆☆☆★
TL;DR: The safety of lidocaine-prilocaine cream (EMLA) was evaluated in an open trial in 30 preterm neonates and methemoglobin levels were not different.
Journal ArticleDOI
Prospective, controlled, multicentre study of loperamide in pregnancy.
Adrienne Einarson,Pier P. Mastroiacovo,Judy Arnon,Asher Ornoy,Antonio Addis,Heli Malm,Gideon Koren +6 more
TL;DR: The results of this study suggest that the use of loperamide during pregnancy is not associated with an increased risk of major malformations.
Journal ArticleDOI
Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography.
TL;DR: An HPLC assay is described for the measurement of prilocaine and lidocaine (components of the local anesthetic cream EMLA) as well as the prilOCaine metabolite, o-toluidine, in plasma, which uses UV detection.
Journal ArticleDOI
Long-term Neurodevelopment of Children Exposed to Maternal Nausea and Vomiting of Pregnancy and Diclectin
TL;DR: NVP has an enhancing effect on later child outcome and diclectin does not appear to adversely affect fetal brain development and can be used to control NVP when clinically indicated.